KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy
Year: 2025
Type: article
Language: en
Topic: PARP inhibition in cancer therapy
Authors and affiliations:
raw_author_name: Hope S. Rugo
raw_affiliation_strings: 1Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California
City Of Hope National Medical Center San Francisco, CA United States
raw_author_name: David W. Cescon
raw_affiliation_strings: Princess Margaret Cancer Centre 2 Department of Medical Oncology, , Toronto, Canada
Princess Margaret Cancer Centre Toronto, Ontario Canada
raw_author_name: Mark E. Robson
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center 3 Department of Medicine, , New York, New York
Memorial Sloan Kettering Cancer Center New York, NY United States
raw_author_name: Seock-Ah Im
raw_affiliation_strings: Seoul National University Hospital 4 Department of Internal Medicine, , Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
Seoul National University Hospital Seoul Korea (South), Republic of
raw_author_name: Florence Dalenc
raw_affiliation_strings: 5Department of Medical Oncology, Oncopole Claudius-Regaud, IUCT, Toulouse, France
Oncopole Claudius Regaud Toulouse France
raw_author_name: Eduardo Yañez Ruiz
raw_affiliation_strings: 6Oncology Unit, Department of Internal Medicine, School of Medicine, Universidad de la Frontera, Temuco, Chile
School of Medicine, Universidad de la Frontera Temuco Chile
raw_author_name: Felipe Reyes-Cosmelli
raw_affiliation_strings: 7Fundación Arturo López Pérez Cancer Center, Santiago, Chile
Fundación Arturo López Pérez Cancer Center Santiago Chile
raw_author_name: Janice M. Walshe
raw_affiliation_strings: St. Vincent’s University Hospital 8 Department of Oncology, , Dublin, Ireland
St. Vincent's University Hospital Dublin 4 Ireland
raw_author_name: Young-Hyuck Im
raw_affiliation_strings: 9Division of Hematology/Medical Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Korea (South), Republic of
raw_author_name: Sergii Kulyk
raw_affiliation_strings: 10Medical Center Verum, Kyiv, Ukraine
Medical Center Verum Kyiv Ukraine
raw_author_name: Oleksandr Dudnichenko
raw_affiliation_strings: 11V. T. Zaitsev Institute of General and Urgent Surgery of Academy of Medical Sciences of Ukraine, Tumors of Visceral Organs and Soft Tissues, Kharkiv, Ukraine
V.T. Zaycev Institute Ukraine
raw_author_name: Néstor Llinás-Quintero
raw_affiliation_strings: 12Clinical Oncology Group, Fundación Colombiana de Cancerología-Clínica Vida, Medellín, Colombia
Fundación Colombiana de Cancerología-Clínica Vida Medellín Colombia
raw_author_name: Shigehira Saji
raw_affiliation_strings: Fukushima Medical University 13 Department of Medical Oncology, , Fukushima, Japan
Fukushima Medical University Fukushima, Fukushima Japan
raw_author_name: Yasuo Miyoshi
raw_affiliation_strings: 14Hyogo Medicine University, Nishinomiya, Japan
Hyogo Medical University Nishinomiyashi, Hyogo Japan
raw_author_name: Aditya Bardia
raw_affiliation_strings: University of California Los Angeles 15 Division of Hematology-Oncology, , Jonsson Comprehensive Cancer Center, Los Angeles, California
University of California, Los Angeles Los Angeles, CA United States
raw_author_name: Nadia Harbeck
raw_affiliation_strings: 16Breast Center, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany
University of Munich Munich Germany
raw_author_name: Amin Haiderali
raw_affiliation_strings: 17Oncology, Merck & Co., Inc., Rahway, New Jersey
Merck & Co., Inc. United States
raw_author_name: Li Fan
raw_affiliation_strings: 17Oncology, Merck & Co., Inc., Rahway, New Jersey
Merck & Co., Inc. Rahway, NJ United States
raw_author_name: Jaime A. Mejia
raw_affiliation_strings: 17Oncology, Merck & Co., Inc., Rahway, New Jersey
Merck Research Laboratories North Wales, PA United States
raw_author_name: Vassiliki Karantza
raw_affiliation_strings: 17Oncology, Merck & Co., Inc., Rahway, New Jersey
MSD (United States) Rahway, NJ United States
raw_author_name: Antonio Llombart-Cussac
raw_affiliation_strings: Hospital Arnau de Vilanova 18 Department of Oncology, , Valencia, Spain
Hospital Arnau de Vilanova Valencia Spain